Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPD Exacerbation and Pulmonary Hypertension Trial
2020-000236-22Phase 4Terminated
- Sponsor
- COPD360Net
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sildenafil in chronic obstructive pulmonary disease (COPD) and pulmonary hypertension (PH), sponsored by COPD360Net. Primary endpoint: Time alive and discharged from hospital within 365 days from baseline. Started Oct 2020; status: terminated.
02
Drugs
sildenafil
03
Conditions
chronic obstructive pulmonary disease (COPD)pulmonary hypertension (PH)
Beyond the preview
Go deeper on 2020-000236-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000236-22.